The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(S)-N-(1-cyanocyclopropyl)-4-methyl-2-(((S)-2,2,2-trifluoro-1-phenylethyl)amino)pentanamide ID: ALA4519995
PubChem CID: 67298247
Max Phase: Preclinical
Molecular Formula: C18H22F3N3O
Molecular Weight: 353.39
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: CC(C)C[C@H](N[C@@H](c1ccccc1)C(F)(F)F)C(=O)NC1(C#N)CC1
Standard InChI: InChI=1S/C18H22F3N3O/c1-12(2)10-14(16(25)24-17(11-22)8-9-17)23-15(18(19,20)21)13-6-4-3-5-7-13/h3-7,12,14-15,23H,8-10H2,1-2H3,(H,24,25)/t14-,15-/m0/s1
Standard InChI Key: UXYWRPKODJHGIP-GJZGRUSLSA-N
Molfile:
RDKit 2D
25 26 0 0 0 0 0 0 0 0999 V2000
18.2382 -5.1590 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8338 -4.4533 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.4248 -5.1564 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1739 -4.4739 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1728 -5.2934 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8808 -5.7024 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5905 -5.2929 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5876 -4.4703 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8790 -4.0650 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2938 -4.0590 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0030 -4.4649 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.7092 -4.0537 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4185 -4.4596 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1246 -4.0484 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.4215 -5.2768 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.5400 -4.0430 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.2443 -3.6297 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.2907 -3.2418 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9969 -2.8306 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
13.5815 -2.8359 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
14.2843 -2.4227 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
15.7061 -3.2365 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4123 -2.8252 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1215 -3.2312 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4092 -2.0081 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 1 0
1 3 1 0
4 5 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 4 1 0
8 10 1 0
10 11 1 0
11 12 1 0
12 13 1 0
13 14 1 0
13 15 2 0
14 2 1 0
2 16 1 0
16 17 3 0
10 18 1 1
18 19 1 0
18 20 1 0
18 21 1 0
12 22 1 1
22 23 1 0
23 24 1 0
23 25 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 353.39Molecular Weight (Monoisotopic): 353.1715AlogP: 3.47#Rotatable Bonds: 7Polar Surface Area: 64.92Molecular Species: NEUTRALHBA: 3HBD: 2#RO5 Violations: ┄HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 11.39CX Basic pKa: 3.52CX LogP: 3.49CX LogD: 3.49Aromatic Rings: 1Heavy Atoms: 25QED Weighted: 0.79Np Likeness Score: -0.82
References 1. Gomes JC, Cianni L, Ribeiro J, Dos Reis Rocho F, da Costa Martins Silva S, Batista PHJ, Moraes CB, Franco CH, Freitas-Junior LHG, Kenny PW, Leitão A, Burtoloso ACB, de Vita D, Montanari CA.. (2019) Synthesis and structure-activity relationship of nitrile-based cruzain inhibitors incorporating a trifluoroethylamine-based P2 amide replacement., 27 (22): [PMID:31561938 ] [10.1016/j.bmc.2019.115083 ]